tirzepatide strength and dosage chart in units: complete conversion guide for every concentration Tirzepatide Dosing - A Patient

13 The SURMOUNT-2 study follows the same methodology as SURMOUNT-1, but it compares tirzepatide 10 mg and 15 mg with placebo in patients with T2DM who have obesity or are overweight

We encourage a thorough discussion with our healthcare providers about potential treatments like tirzepatide, considering not only the cost but also the medications potential benefits and side effects

Minor Side Effects As with any medication, Tirzepatide injections may cause mild side effects

others will discuss restarting earlier with their clinical team

Sitagliptin, a dipeptidyl peptidase-4 inhibitor, was selected as an active-comparator placebo proxy because it was recommended in clinical guidelines as a second-line glucose-lowering therapy, had a similar high cost to the study drugs, showed no effect on cardiovascular outcomes in a large randomized controlled trial and has been validated as a placebo proxy in prior claims-based research 20,41